Copyright
©The Author(s) 2024.
World J Clin Oncol. Feb 24, 2024; 15(2): 195-207
Published online Feb 24, 2024. doi: 10.5306/wjco.v15.i2.195
Published online Feb 24, 2024. doi: 10.5306/wjco.v15.i2.195
Cancer type | IFNGR1 expression | IFNGR2 expression |
Bladder urothelial carcinoma | No change | Upregulated |
Breast invasive carcinoma | Downregulated | Upregulated |
Cholangiocarcinoma | Upregulated | Upregulated |
Colon adenocarcinoma | Downregulated | Downregulated |
Esophageal carcinoma | Upregulated | Upregulated |
Glioblastoma multiforme | Upregulated | Upregulated |
Head and neck squamous cell carcinoma | Upregulated | Upregulated |
Kidney chromophobe | Downregulated | Downregulated |
Kidney renal clear cell carcinoma | Upregulated | Upregulated |
Kidney renal papillary cell carcinoma | Upregulated | Upregulated |
Liver hepatocellular carcinoma | Upregulated | Upregulated |
Lung adenocarcinoma | Downregulated | Upregulated |
Lung squamous cell carcinoma | Downregulated | Upregulated |
Pancreatic adenocarcinoma | Downregulated | No change |
Prostate adenocarcinoma | No change | Upregulated |
Rectum adenocarcinoma | Downregulated | No change |
Skin cutaneous melanoma | Downregulated | No change |
Stomach adenocarcinoma | Upregulated | Upregulated |
Thyroid carcinoma | No change | Upregulated |
Uterine corpus endometrial carcinoma | Downregulated | Upregulated |
- Citation: Tecalco-Cruz AC, Medina-Abreu KH, Oropeza-Martínez E, Zepeda-Cervantes J, Vázquez-Macías A, Macías-Silva M. Deregulation of interferon-gamma receptor 1 expression and its implications for lung adenocarcinoma progression. World J Clin Oncol 2024; 15(2): 195-207
- URL: https://www.wjgnet.com/2218-4333/full/v15/i2/195.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i2.195